StockDuty

Market Signals

Real-time investor intelligence from StockDuty.

ASML vs. Taiwan Semiconductor: Which Semiconductor Monopoly Is the Safer Investment?
Catalyst Tech/AI · 62d ago
How Qiagen’s New Automation Platform, CEO Transition and Q2 Beat Will Impact Qiagen (QGEN) Investors
Catalyst Earnings · 62d ago
U.S.-VENEZUELA OIL DEAL WON'T REDUCE DOMESTIC GASOLINE PRICES ANYTIME SOON, EXPERTS SAY - PBS
Catalyst Commodities · 62d ago
US DOLLAR PRICE FORECAST: DXY WEAKENS AHEAD OF NFP; EUR/USD AND GBP/USD RECOVER - YAHOO
Catalyst Fixed Income · 62d ago
NIFTY’S 21-DAY CALM BEFORE THE STORM? HISTORY WARNS OF A SHARP MOVE AHEAD - ECONOMICTIMES
Catalyst India · 63d ago
FROM TRUMP’S TAKEOVER THREATS TO A ‘NORTHERN NEIGHBORHOOD,’ WHY THE EU CHIEF IS GOING TO GREENLAND - CNBC
Catalyst Corporate · 63d ago
Coatue Opened Positions in Intel and Cerebras. Is the AI Chip Trade Broadening Beyond NVIDIA?
Catalyst Tech/AI · 63d ago
Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen
Catalyst FDA/Bio · 63d ago
WATCH: TRUMP CALLS IRAN WAR 'SMALL POTATOES' AND 'VERY INTERMITTENT' - PBS
Catalyst Geopolitics · 63d ago
TSMC (TSM) Increases Despite Market Slip: Here's What You Need to Know
Catalyst Tech/AI · 63d ago
Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial
Catalyst FDA/Bio · 63d ago
Guardant Health Announces Landmark FDA Approval of Guardant360® CDx as Companion Diagnostic for AstraZeneca’s ETCAMAH™ (camizestrant) in Advanced Brea
Catalyst FDA/Bio · 63d ago
TRUMP SAYS SKILLED FOREIGN WORKERS TAKE JOBS AWAY FROM AMERICANS. IT'S NOT THAT SIMPLE, EXPERTS SAY - PBS
Catalyst Geopolitics · 63d ago
Ionis partner Novartis announces Lp(a)HORIZON Phase 3 topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular di
Catalyst FDA/Bio · 63d ago
ASML Plans 40% Japan Workforce Expansion to Support Chip Boom
Catalyst Tech/AI · 63d ago
Jazz (JAZZ) Says Ziihera Beat Trastuzumab on Overall Survival. Can it Replace the First-Line HER2 Backbone?
Catalyst FDA/Bio · 63d ago
This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.
Catalyst FDA/Bio · 63d ago
US DIESEL PRICES HIT AN ALL-TIME-HIGH - BBC
Catalyst Commodities · 63d ago
ROBOTS CANNOT STOP AND WAIT FOR MODELS: XINGCHEN RELEASES SMOOTHRL, ENABLING ONLINE REINFORCEMENT LEARNING TO KEEP UP WITH ASYNCHRONOUS INFERENCE OF L
Catalyst Tech/AI · 63d ago
ARGENTINE LEADER THREATENS TO SANCTION OIL FIRMS AND REITERATES FALKLANDS CLAIM - BBC
Catalyst Geopolitics · 63d ago
NATION'S FIRST! RUIGAN ROBOT OBTAINS THE HIGHEST-LEVEL GAS AND DUST DUAL EXPLOSION-PROOF FOUR-WHEELED FOOT CERTIFICATION. - ZHIDX
Catalyst Tech/AI · 63d ago
AbbVie (ABBV) Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma
Catalyst FDA/Bio · 64d ago
Planet Labs PBC (PL) (Q2 2027) Earnings Call Highlights: Record Revenue and Strategic Expansion ...
Catalyst Earnings · 64d ago
STATE-RUN FIRMS' RESTRUCTURING AIMED AT REFORM, NOT COST CUTS: OFFICIAL - YONHAP
Catalyst Macro · 64d ago
Does Marvell (MRVL) Signal Patience or Urgency With Its AI Data Center Timeline and Buybacks?
Catalyst Tech/AI · 64d ago
LAST EMERGENCY FUNDING WINDOW TIGHTENS AS LOAN COSTS SURGE, RATES CAPPED - CHOSUN ILBO - GNEWS
Catalyst Macro · 64d ago
Former Meta Superintelligence Labs Agentic AI Lead Joins Project 777, Strengthening Technical Leadership Alongside Former U.S. Space Force CTO Preston
Catalyst Tech/AI · 64d ago
OPENAI COMMITS $1B TO SUBSIDIZE DAYBREAK CYBER TOOLS FOR ORGANIZATIONS - SEEKINGALPHA
Catalyst Tech/AI · 64d ago
ASML (ASML) Stock Sinks As Market Gains: What You Should Know
Catalyst Tech/AI · 64d ago
AVGO Q2 Deep Dive: AI Semiconductor Surge Faces Supply Headwinds and Guidance Caution
Catalyst Tech/AI · 64d ago
AVGO Q3 Earnings Beat Estimates, Revenues Rise on Strong AI Demand
Catalyst Earnings · 64d ago
"WELCOME TO THE AGI ERA," OPENAI SAYS AS GPT-6 ASTRA DEBUTS - HN
Catalyst Tech/AI · 64d ago
Will Barclays' Expansion Initiatives Accelerate Top-Line Growth?
Catalyst EU/UK · 64d ago
Data Center Solutions Market Surges to $1,336.55 billion at a CAGR 20.1% by 2031 | Report by MarketsandMarkets™
Catalyst Tech/AI · 64d ago
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free S
Catalyst FDA/Bio · 64d ago
ALIBABA UPDATES ITS FLAGSHIP MODEL QWEN3.8-MAX, FRONT-END PROGRAMMING CAPABILITY LEAPS TO WORLD NO.1 - QBITAI
Catalyst Tech/AI · 64d ago
Ultragenyx drops on Phase 3 trial failure for Angelman syndrome drug
Catalyst FDA/Bio · 65d ago
US backs AI training as fair use in OpenAI copyright case
Catalyst Tech/AI · 65d ago
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Catalyst EU/UK · 65d ago
FuelCell Sinks 13% as Wider Loss Overshadows First Data Center Reservation Deal, Bloom Energy Slips, Plug Power Barely Budges
Catalyst Tech/AI · 65d ago
NYSE uses Anthropic’s Mythos to find cyber security flaws
Catalyst Tech/AI · 65d ago
Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanc
Catalyst FDA/Bio · 65d ago
Good morning.
Catalyst Fixed Income · 65d ago
BAYER AKTIENGESELLSCHAFT (BAYRY) DISCUSSES INNOVATION STRATEGY AND PROGRESS ON FIVE-YEAR GROWTH FRAMEWORK IN CROP SCIENCE DIVISION TRANSCRIPT - SEEKIN
Catalyst EU/UK · 65d ago
INDIA GETS RECORD $127 BILLION UNDER FCNR WINDOW - MINT
Catalyst India · 65d ago
Broadcom Inc. (AVGO) Q3 Earnings and Revenues Beat Estimates
Catalyst Earnings · 65d ago
US COURT RULES GOOGLE WILL NOT HAVE TO SELL AD EXCHANGE AFTER LOSING ANTITRUST CASE - ARSTECHNICA
Catalyst Corporate · 65d ago
AI AGENTS ARE HACKING SYSTEMS WITHOUT ANY INPUT FROM HUMANS. HOW DID WE GET HERE? - PBS
Catalyst Tech/AI · 65d ago
TRUMP TO MEET WITH TRAVEL INDUSTRY CEOS AS WHITE HOUSE TOUTS WORLD CUP TOURISM BOOST - CNBC
Catalyst Geopolitics · 65d ago
Google escapes DOJ bid to break up its ad tech business
Catalyst Corporate · 65d ago